Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease

Abstract

Metabolic syndrome is independently associated with an increased 20-year all-cause mortality risk among patients with stable CAD. This association was consistent when either the IDF or NCEP definitions were used. Trial registration retrospective registered.